Epivir Hbv (Lamivudine) – Patient Information (UK)

Epivir Hbv is a brand of lamivudine, an antiviral medicine used in the treatment of certain types of hepatitis B infection. This page explains how it works, how it is usually taken, key safety considerations, and what to expect in everyday life.

Always read the Patient Information Leaflet supplied with your medicine for the most up-to-date advice specific to your product and condition.

Quick overview

• Medicine: Lamivudine
• Brand: Epivir Hbv
• Use: Antiviral treatment for chronic hepatitis B (HBV)
• Common form: Oral tablets or oral formulation (strengths vary by product)
• How it helps: Reduces the amount of hepatitis B virus in the body
• Important note: Long-term use may be needed, and virus resistance can develop over time

What is Epivir Hbv?

Epivir Hbv contains lamivudine, an antiviral medicine that belongs to a group called nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs).

Lamivudine works mainly by interfering with how hepatitis B reproduces inside liver cells. It is used for the management of chronic hepatitis B (HBV), including in people with active viral replication and liver inflammation or disease.

Indications: when it is used in the UK

In the UK, lamivudine is used for:

• Chronic hepatitis B infection, particularly when there is evidence of viral replication and liver inflammation or damage.
• Some patients may be advised lamivudine as part of a specialist treatment plan depending on viral load, liver function, severity, and prior therapy history.

Specialist oversight is important because hepatitis B treatment decisions take into account risk of resistance, liver status, kidney function, and whether you have other liver conditions or take interacting medicines.

How Epivir Hbv works (mechanism of action)

Lamivudine is taken by mouth and absorbed into the bloodstream. Inside liver cells, it is converted into its active form, which then:

• Blocks the viral enzyme reverse transcriptase that hepatitis B uses to copy its genetic material.
• Reduces the production of new HBV DNA.
• Helps lower viral load, which can improve liver inflammation and slow progression of liver disease.

Over time, successful treatment aims to achieve control of the virus (for example, lower viral load and improvements in liver enzyme levels). In many cases, monitoring includes blood tests for HBV DNA and liver function.

Pharmacokinetics: how the body handles lamivudine

Pharmacokinetics describes absorption, distribution, metabolism, and elimination. Key points include:

• Absorption: Lamivudine is absorbed after oral dosing, with peak levels typically occurring within a few hours (timing can vary between individuals).
• Distribution: It distributes through the body, including to tissues where HBV replicates, such as the liver.
• Metabolism: Lamivudine is not extensively metabolised by the liver.
• Elimination: Lamivudine is mainly cleared by the kidneys. This means dose adjustments may be needed in people with reduced kidney function.
• Accumulation: If kidney function is impaired, lamivudine can build up in the body, increasing risk of side effects.

Typical dosing in adults (general guidance)

Dosing varies by patient factors such as kidney function and the specific product strength. Your regimen will be chosen by a clinician based on your situation.

Common adult dosing patterns for chronic hepatitis B include:

• Once daily dosing is commonly used for chronic hepatitis B treatment.
• Some circumstances may use different dosing schedules depending on the product and clinical plan.

Kidney impairment: Because lamivudine is cleared via the kidneys, dose adjustment is often required for people with reduced renal function.

Practical point: If you are unsure of your strength or how many tablets to take, check the packaging and ask your pharmacist for confirmation.

When to take Epivir Hbv (timing and missed doses)

Lamivudine is usually taken at the same time each day to help maintain consistent antiviral levels.

Taking it with or without food

• Lamivudine can generally be taken with or without food.
• Some people find it easier on the stomach when taken with a meal.

If you miss a dose

• If you remember soon after missing a dose, take it as soon as practical.
• If it is close to your next dose, skip the missed dose and continue your normal schedule.
• Do not double up to make up for a missed tablet.

If you miss multiple doses or are unsure what to do, contact your healthcare team or pharmacist for advice.

Food interactions

There are no major food restrictions for lamivudine for most people.

• Normal meals: Taking with food or on an empty stomach is generally acceptable.
• Consistency helps: Try to keep your routine consistent (same time of day) to support adherence.

Alcohol and medicine interactions

Alcohol

If you have chronic hepatitis B, alcohol may worsen liver inflammation and damage. It is generally recommended to avoid or minimise alcohol as much as possible.

Interactions with other medicines

Lamivudine is not extensively metabolised by the liver, and it has relatively fewer drug–drug interactions than some other antivirals. However, interactions can still occur, especially with medicines that affect kidneys or other antivirals.

Tell your clinician/pharmacist if you take:

• Other antiviral medicines
• Medicines that affect kidney function (e.g., some antibiotics, anti-inflammatory medicines taken regularly)
• Medicines containing sorbitol or combination products that might affect absorption (your pharmacist can advise)
• Any over-the-counter remedies or herbal products

Safety tip: Keep an up-to-date list of all medicines and bring it to appointments.

Safety profile: what to watch for

Like all medicines, Epivir Hbv can cause side effects. Many are mild, but some require prompt medical attention.

Common side effects

• Headache
• Nausea or upset stomach
• Fatigue
• General discomfort

Less common but important side effects

• Liver-related changes: Symptoms such as worsening tiredness, abdominal pain, dark urine, or yellowing of the skin/eyes should be assessed urgently.
• Pancreatitis symptoms: Severe upper abdominal pain, with or without vomiting, should be reported urgently.
• Allergic reactions: Rash, swelling of the face/lips, or trouble breathing require emergency help.

Rare but serious risks

With antiviral NRTIs, there is a rare risk of lactic acidosis and severe liver enlargement. These risks are uncommon, but you should seek urgent medical help if you develop:

• Rapid or deep breathing
• Unusual weakness, severe fatigue
• Persistent nausea/vomiting
• Abdominal pain

Monitoring during treatment

Regular monitoring is a key part of safe hepatitis B therapy. Your clinician may check:

• HBV DNA (viral load)
• Liver function tests (ALT/AST, bilirubin)
• Full blood count as appropriate
• Kidney function (especially if you have reduced renal function)

Practical use tips to improve outcomes

• Adherence is crucial: Taking lamivudine consistently supports better viral suppression.
• Don’t stop suddenly without advice: Stopping can lead to viral flare in some patients. Decisions about stopping or switching should be made with your clinician.
• Use reminders: Pill boxes, phone alarms, or medication apps can help.
• Check your kidney health: If you have kidney disease, make sure your prescriber/pharmacist knows.
• Keep regular appointments: Lab monitoring helps detect resistance early and assess liver progress.
• Watch symptoms: Report jaundice, severe fatigue, abdominal pain, or breathing difficulties promptly.

Resistance and long-term considerations

A key issue with lamivudine for hepatitis B is that the virus can develop resistance over time. Resistance may reduce long-term effectiveness.

Because of this, clinicians may consider:

• Whether lamivudine is the best option for your specific case
• Switching to or starting with medicines with a higher genetic barrier to resistance (as appropriate)
• Careful viral load monitoring to detect inadequate response

Your treatment plan should reflect your individual risk profile and local guidance.

Alternative options (what else may be used for chronic HBV)

For chronic hepatitis B, there are multiple antiviral options. The choice depends on factors such as viral load, liver disease severity, prior treatment, and resistance risk.

Common alternatives that may be considered by clinicians include:

• Entecavir
• Tenofovir disoproxil or tenofovir alafenamide (availability and suitability vary)
• Other specialist regimens depending on circumstances

If you are comparing options, ask your pharmacist or clinician what is most appropriate for your condition and kidney/liver health.

Delivery and availability in the United Kingdom

Epivir Hbv (lamivudine) is a well-known medicine available through the UK medicines supply system. Availability can vary between strengths and formulations, and stock levels may change.

• Dispensing and supply: Many UK pharmacies can supply scheduled medicines when available from wholesalers.
• Online pharmacies: Availability is subject to stock at the time of order.
• Delivery: Delivery options typically depend on the provider and the service area. Some suppliers offer standard and express delivery.

Storage: Keep tablets according to the instructions on the packaging (typically at room temperature, protected from excessive heat and moisture). Keep out of the sight and reach of children.

Market and legal context in the UK (overview)

In the UK, antiviral medicines for chronic hepatitis B are regulated and supplied under the Medicines and Healthcare products Regulatory Agency (MHRA) framework. Patient-facing information is intended to help you understand your medicine safely.

Guidance and prescribing decisions for hepatitis B are usually overseen by clinicians with expertise in liver disease, and treatment plans reflect evidence-based recommendations from UK and international health bodies.

Pharmacy providers must follow UK medicines regulations regarding safe supply, verification of patient details, and controlled handling where applicable.

Recent guidance and clinical practice (UK context)

Clinical practice for chronic hepatitis B continues to evolve, with increasing emphasis on:

• Viral load monitoring to confirm effectiveness
• Resistance risk and choosing medicines with more durable suppression when appropriate
• Assessment of liver disease stage and ongoing surveillance for complications
• Individualised therapy based on kidney function, previous treatment, and patient-specific factors

Local policies may recommend different first-line or second-line choices depending on resistance patterns and the individual patient’s situation.

Frequently Asked Questions (FAQ)

1) What is Epivir Hbv used for?

Epivir Hbv (lamivudine) is used to treat chronic hepatitis B. It helps reduce HBV replication and viral load, which can improve liver inflammation and slow progression of liver disease.

2) How quickly will it work?

Viral suppression can begin within weeks, but response varies. Your clinician will monitor blood tests (such as HBV DNA and liver enzymes) to confirm that the virus is responding.

3) Is it safe to take long-term?

Many people take nucleoside antivirals long-term. The risk–benefit balance depends on your disease status and response. Long-term use also requires careful monitoring due to possible resistance and side effects.

4) Can I take it with food?

Yes. Lamivudine is generally taken with or without food. Choose a routine you can keep consistently.

5) What if I accidentally miss a dose?

Take it if you remember soon after. If it’s nearly time for your next dose, skip the missed one. Do not double up. If missed doses become frequent, seek advice.

6) Will alcohol affect my hepatitis B or the medicine?

Alcohol can worsen liver inflammation and damage in people with hepatitis B. It’s generally advisable to avoid or minimise alcohol. Alcohol doesn’t usually have a direct “interaction” with lamivudine, but it may worsen liver outcomes.

7) Are there medicines I should avoid?

Tell your pharmacist/clinician about all medicines, including over-the-counter products and supplements. Medicines that affect kidney function may require caution, since lamivudine is cleared by the kidneys.

8) How do I know if I’m developing resistance?

Resistance is usually detected through blood tests showing rising HBV DNA or reduced viral suppression despite treatment. Regular monitoring is the best way to identify this early.

9) What should I do if I feel unwell while taking Epivir Hbv?

Mild side effects may settle, but seek urgent advice if you develop symptoms such as jaundice, severe abdominal pain, breathing difficulties, or signs of an allergic reaction.

10) Are there alternatives to lamivudine?

Yes. Other antivirals may be suitable depending on your case, such as entecavir and tenofovir options. Your clinician can recommend the most appropriate approach.

Summary

Epivir Hbv (lamivudine) is an oral antiviral medicine used for chronic hepatitis B. It helps reduce HBV replication by targeting a key viral enzyme involved in copying viral DNA. Because lamivudine is largely cleared through the kidneys, kidney function matters for safe use. Side effects are often mild, but regular monitoring is essential to track liver health, viral response, and (over time) the risk of resistance.

If you have questions about dosing timing, missed doses, or interactions with your other medicines, speak to your pharmacist or healthcare team.